What we do Jeevan Scientific Technology Limited is an independent Clinical Contract Research Organization providing clinical research, data management, and medical writing services globally to pharmaceutical and biotech industries. |
Founded in 1,999 |
Market share A recognized CRO with increasing exports and UK MHRA inspected facilities, serving global pharmaceutical clients. |
Problem solved Facilitates efficient, reliable clinical research and bioanalytical services to speed drug development and regulatory approvals. |
Top clients or who we serve Pharmaceutical, biotechnology companies worldwide; B2B clinical research and bioanalytical service providers. |
Key management - |
Our journey and innovations Started in 1999 with IT and clinical services; evolved to full clinical research and bioanalytical services with advanced labs and global certifications. |
Where we operate Primarily India, with significant exports to USA and UK markets via global client base. |
Top products or what we offer Clinical research services including BA/BE studies, Phase I-IV trials, medical writing, bioanalytics; IT services in clinical data management. |
Top brands - |
Raw materials needed - |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue is mostly recurring through ongoing clinical service contracts. |
Our industry position Moderate market player with niche biopharma CRO services, expanding footprint and capabilities. |
Financial highlights FY 2024-25 revenue approx. Rs. 46.84 crores, net profit Rs. 0.13 crores consolidated, showing turnaround and growth. |
Geographical revenue split India contributes about 67%, outside India 33% to revenues as of latest data. |
Order book - |
Whats driving growth Investments in advanced labs, new UK MHRA certifications, expanding bioanalytical capabilities, global pharma demand. |
Our future plans Focus on expanding clinical pharmacology units, increasing quality accreditations, and growing UK/USA service contracts. |
Our green promise - |
Our people and values Emphasizes talent retention through ESOPs, training, and ethical practices fostering innovation and compliance. |
Key challenges ahead Competition from global CROs, regulatory complexities, and maintaining profit margins amid expansions. |
Interesting facts Operates a 132-bed Clinical Pharmacology Unit; launched India’s first UK MHRA inspected bioanalytical labs. |
Risks and strategy Mitigates regulatory and market risks by diversifying client base, upgrading technology, and strengthening governance. |
